Skip to content

Implementation of a Cancer Risk Assessment Program Using Genetic Testing in the General Female Population

Implementation of a Cancer Risk Assessment Program Using Genetic Testing in the General Female Population - Implementation of a Cancer Risk Assessment Program Using Genetic Testing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056304
Enrollment
400
Registered
2024-12-01
Start date
2025-01-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary cancer

Interventions

Study participants will undergo a hereditary tumor risk assessment program designed for the general population. In this program, genetic testing is recommended if their family and medical history meet

Sponsors

Kanagawa Cancer Center Research Institute
Lead Sponsor
You-wa-kai Medical Corporation Association
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Use age and gender as the only selection criteria.

Exclusion criteria

Exclusion criteria: - Individuals diagnosed with hereditary tumors - Individuals whose close relatives have been diagnosed with hereditary tumors and who have access to genetic counseling as a relative - Individuals with a confirmed germline pathogenic variant in the BRCA1 and/or BRCA2 genes within their family - Individuals unable to answer the questionnaire - Individuals unable to communicate in Japanese

Design outcomes

Primary

MeasureTime frame
Program completion rate

Secondary

MeasureTime frame
- Completion rate of the family and medical history screening questionnaire - Proportion of individuals with pathogenic variants among the study participants - Proportion of study participants meeting the criteria for genetic testing - Proportion of individuals with pathogenic variants among those who underwent genetic testing - Proportion of individuals with detected pathogenic variants who received genetic counseling - Proportion of individuals meeting genetic testing criteria by level of criteria

Countries

Japan

Contacts

Public ContactHiroto Narimatsu

Kanagawa Cancer Center Research Institute Cancer Prevention and Control Division

hiroto-narimatsu@umin.org045-520-2222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026